Unique ID issued by UMIN | UMIN000001334 |
---|---|
Receipt number | R000001620 |
Scientific Title | Randomized study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) with vs. without rapid on-site cytologic evaluation (ROSE) in the diagnosis of lung cancer |
Date of disclosure of the study information | 2008/08/25 |
Last modified on | 2014/06/11 09:36:57 |
Randomized study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) with vs. without rapid on-site cytologic evaluation (ROSE) in the diagnosis of lung cancer
Comparison of EBUS-TBNA with vs. without ROSE
Randomized study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) with vs. without rapid on-site cytologic evaluation (ROSE) in the diagnosis of lung cancer
Comparison of EBUS-TBNA with vs. without ROSE
Japan |
Lung cancer
Pneumology |
Malignancy
NO
To assess the utility of ROSE on EBUS-TBNA in the diagnosis of lung cancer
Safety,Efficacy
Confirmatory
Pragmatic
Phase III
1. Yields for eliminating the need for additional bronchoscopic procedures
1. Diagnostic yields (EBUS-TBNA, overall bronchoscopy)
2. Accuracy of EBUS-TBNA
3. Number of needle passes
4. Time of procedure (EBUS-TBNA, overall bronchoscopy)
5. Accuracy of ROSE
6. Frequency of adverse effects
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Diagnosis
Device,equipment |
EBUS-TBNA with ROSE
EBUS-TBNA without ROSE
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients suspected to have lung cancer with enlarged mediastinal and/or hilar lesions 10 mm or greater in short-axis diameter on CT
2. 20 years old or more
3. Informed consent
1. Patients with known lung cancer (e.g., mediastinal staging purposes)
2. Endobronchial lesions
3. Patients with severe concomitant medical illness
4. Bleeding tendency
5. Pregnant woman
6. Other clinical difficulties in this study
120
1st name | |
Middle name | |
Last name | Masahide Oki |
Nagoya Medical Center
Department of Respiratory Medicine
4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan
052-951-1111
1st name | |
Middle name | |
Last name | Masahide Oki |
Nagoya Medical Center
Department of Respiratory Medicine
4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan
052-951-1111
masahideo@aol.com
Nagoya Medical Center
None
Self funding
NO
2008 | Year | 08 | Month | 25 | Day |
Published
http://www.karger.com/Article/FullText/346987
Twelve patients with visible endobronchial lesions were excluded in the analysis. Thus, a total of 108 patients (55 in ROSE group; 53 in non-ROSE group) were analyzed. Additional procedures including EBUS-TBNA for lesions other than the main target lesion and/or transbronchial biopsy in the same setting were performed in 11% of patients in the ROSE group and 57% in the non-ROSE group (p < 0.001). Mean puncture number was significantly fewer in the ROSE group (2.2 vs. 3.1 punctures, p < 0.001). Mean bronchoscopy time was similar between both groups (22.3 vs. 22.1 min, p = 0.95). The sensitivity and accuracy for diagnosing lung cancer were 88% and 89% in the ROSE group, and 86% and 89% in the non-ROSE group, respectively. No complications were associated with the procedures.
Completed
2008 | Year | 08 | Month | 08 | Day |
2008 | Year | 08 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2008 | Year | 08 | Month | 22 | Day |
2014 | Year | 06 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001620